Navigation Links
You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes'

MINNEAPOLIS, Jan. 5 /PRNewswire/ -- In their latest book, You: Being Beautiful - The Owner's Manual to Inner and Outer Beauty (Free Press, 2008), co-authors Mehmet Oz, MD and Michael Roizen, MD refer to ribose as one of the decade's "real nutritional heroes" that can "turbo-charge" those who need an energy boost. Ribose is a naturally occurring 5-carbon sugar the body uses to stimulate the production of adenosine triphosphate (ATP) -- an essential energy compound.

Although ribose is produced by the body, this energy molecule cannot be replenished fast enough during certain times of demanding exercise, stress, or as a result of many chronic diseases. When added to foods and dietary supplements, D-Ribose enhances the body's natural process of energy synthesis. It reduces the loss of energy during stress, and accelerates energy and tissue recovery and the management of free radicals.

According to Jacob Teitelbaum, MD, Medical Director of the national Fibromyalgia and Fatigue Centers, Inc., and best-selling author of From Fatigued to Fantastic! (Penguin Group), we are in the midst of a human energy crisis. "We're witnessing an emerging worldwide exhaustion epidemic," said Teitelbaum. "The increased stress of modern life combined with poor sleep and nutrition is being reflected not only in the high levels of fatigue but in the accompanying epidemic of pain currently experienced by one in four Americans along with heart disease, the number one killer in the United States."

Dr. Teitelbaum's research published in the Journal of Alternative and Complementary Medicine (12:9, 2006), found a full two-thirds of his patients reported improvement of their symptoms in the first 12 days following a course of Corvalen(R) D-Ribose treatment. The average improvement in energy was 45 percent and quality of life improved an average of 30 percent. Patients reported less muscle soreness and stiffness, better ability to overcome fatigue, as well as simply feeling better. "Supplemental Corvalen(R) is part of a clinically proven program we've developed that is helping millions of people overcome the debilitating effects of Chronic Fatigue Syndrome and fibromyalgia as well as a general malaise of exhaustion," said Teitelbaum. Corvalen(R) is also used by physicians to treat congestive heart failure and to prepare patients for off-pump bypass surgery(1).

"Bioenergy D-Ribose(TM) also has sweeping applications for healthy people who need more energy every day," said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. "It is already widely used as an effective training and recovery tool by high-performance athletes. We've only scratched the surface on the wide-ranging health and training benefits of this nutritional powerhouse."

Bioenergy, Inc. -- The Ribose Company(TM) -- (, recently achieved GRAS (generally recognized as safe) status for D-Ribose from the U.S. Food and Drug Administration. The privately held, Minneapolis-based life sciences company has amassed a large body of scientific literature on the uses of ribose for people across all age and health categories. It has more than 40,000 customers for its proprietary Corvalen(R) products alone, and millions worldwide use Bioenergy D-Ribose(TM) in other functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-Ribose(TM) is included as an ingredient in approximately 100 products. The company's core technology lies in the development and commercialization of products based on the physiological benefits of D-Ribose for health and wellness.

    (1) D. Perkowski, MD, S. Wagner, RN, A. Marcus, MD, J. St. Cyr, MD, Ph.D.,
        Saddleback Hospital, Orange Co., CA, "D-Ribose Improves Cardiac
        Indices in Patients Undergoing "Off-Pump" Coronary Arterial
        Revascularization," presented at Academic Surgical Congress, February

SOURCE Bioenergy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. A Scientist Dechipers the Code to Beautiful, Healthy Skin in The New Science of Perfect Skin
2. With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
3. PNAS paper and its authors honored for scientific excellence
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
8. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
9. Pharmasset Appoints Michael Rogers as Chief Development Officer
10. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
11. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):